Press release
Transcatheter Pulmonary Valve (TPV) Market to be at Forefront by 2025
Report Overview @ https://www.persistencemarketresearch.com/market-research/transcatheter-pulmonary-valve-market.asp
Transcatheter pulmonary valve used in patients born with heart defects, who is having failing conduit. Transcatheter pulmonary valve helps patients to delay the time when a patient needs additional open heart surgery. Transcatheter pulmonary valve also reduces the total number of open heart surgeries a patient needs in life time.
Transcatheter Pulmonary Valve (TPV) market is driven by increasing prevalence of comorbidities like diabetes and cardiovascular diseases coupled with increasing incidence of Congestive Heart Diseases (CHD) among varied patient age groups. Transcatheter pulmonary valve mainly indicated for extension of functional life of RV-PA conduit, for restoring pulmonary valve competence, and for relieving conduit stenosis without inducing regurgitation in patients which makes the transcatheter pulmonary valve market lucrative over the forecast period.
In addition, valves effectives in prolonging the open heart surgeries backed with robust clinical effectiveness in three clinical trials is expected to boost the revenue growth of transcatheter pulmonary valve market over the forecast period. However, low target population for therapy and snail pace adoption in both developing and developed economies expected to may impact the transcatheter pulmonary valve market revenue growth negatively over the forecast period.
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/14152
Transcatheter Pulmonary Valve (TPV) market is undergoing market changes due to promising clinical development of newer technologies in the pipeline and increasing demand for minimally invasice therapies among healthcare fraternity and patient groups. The first Transcatheter Pulmonary Valve (TPV) was introduced by Medtronic plc in 2010 under a Humanitarian Device Exemption (HDE), a regulatory approval for treatments intended for fewer than 4,000 U.S. patients per year. Later in 2015, Medtronic plc received Pre-Market Approval (PMA) from U.S. regulator Food and Drug Administration (FDA) company’s device Melody based on significant clinical evidence from three clinical trials.
Geographically, Transcatheter Pulmonary Valve (TPV) market is segmented into regions viz. North America, Latin America, Europe, Asia Pacific and Japan, Middle East and Africa. North America and Europe region is projected to maintain its lions share over the forecast period. Advanced healthcare infrastructure, availability well equipped healthcare professionals is expected to propel the demand for Transcatheter Pulmonary Valve (TPV) during the forecast period in the above mentioned region. Asia Pacific region is expected to be the moderately growing regional market. Growing healthcare facilities, increased healthcare awareness, and conducive regulatory environment are mainly generating the demand for Transcatheter Pulmonary Valve (TPV) in the region.
The players in Transcatheter Pulmonary Valve (TPV) market include Medtronic plc., Edwards Lifesciences Corporation, VENUS MEDTECH etc.
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/14152
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transcatheter Pulmonary Valve (TPV) Market to be at Forefront by 2025 here
News-ID: 908120 • Views: …
More Releases from Persistence Market Research
Artificial Intelligence as a Service Market Forecasted to Grow at 34.6% CAGR, Re …
The Artificial Intelligence as a Service (AIaaS) market has emerged as one of the most transformative segments in the global technology ecosystem. By providing AI capabilities on a subscription or pay-per-use model, AIaaS allows organizations to deploy advanced AI functionalities without the need for significant in-house infrastructure. This model has democratized access to AI, enabling small and medium-sized enterprises to leverage predictive analytics, natural language processing, and machine learning tools…
Server Operating System Market Anticipated to Witness Robust Growth, Reaching US …
The server operating system market is witnessing robust growth, driven by the rapid expansion of data centers and the surging adoption of cloud technologies across enterprises worldwide. Server operating systems form the backbone of modern IT infrastructure, enabling organizations to efficiently manage hardware resources, deploy applications, and maintain high levels of system reliability and security. As businesses increasingly migrate to cloud environments and data-intensive operations grow, demand for powerful, scalable,…
Manufacturing Operations Management Software Industry Anticipated to Witness Rap …
The Manufacturing Operations Management (MOM) software market is rapidly emerging as a cornerstone of digital transformation in the manufacturing sector. As industries increasingly adopt Industry 4.0 practices, the need for advanced solutions that integrate production planning, real-time monitoring, quality control, and process optimization has surged. MOM software enables manufacturers to streamline operations, reduce production downtime, and improve overall efficiency, making it an indispensable tool across automotive, pharmaceutical, aerospace, and consumer…
G.Fast Chipset Market Forecast to Expand with Absolute $ Growth of USD 28.3 Bill …
The G.Fast chipset market has emerged as a pivotal segment within the broadband and telecommunication infrastructure industry, driven by the rising demand for high-speed internet and improved last-mile connectivity solutions. With advancements in fiber-to-the-distribution-point (FTTdp) networks, the adoption of G.Fast chipsets has witnessed unprecedented growth across residential, commercial, and industrial applications. These chipsets enable ultra-fast broadband speeds over existing copper lines, bridging the performance gap between fiber and legacy infrastructures,…
More Releases for Transcatheter
Transcatheter Valve Market Future Prediction Report By 2032
The global transcatheter valve market was valued at approximately USD 9.7 billion in 2022 and is projected to reach around USD 31.54 billion by 2032, reflecting a compound annual growth rate (CAGR) of 14% during the forecast period from 2024 to 2032.
Transcatheter Valve Market Overview
The global transcatheter valve market is experiencing rapid growth, driven by the increasing prevalence of cardiovascular diseases and the rising adoption of minimally…
Major Market Shift in Transcatheter Embolization And Occlusion Devices Industry: …
What Is the Forecasted Market Size and Growth Rate for the Transcatheter Embolization And Occlusion Devices Market?
The market size of transcatheter embolization and occlusion devices has seen swift expansion in recent years. It is predicted to escalate from $4.76 billion in 2024 to $5.28 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%. The surge during the historic era can be ascribed to the expansion in…
Transcatheter Heart Valve Replacement Market Forecast Report By Type (Transcathe …
Global Transcatheter Heart Valve Replacement Market
The global Transcatheter Heart Valve Replacement (THVR) market is poised for significant growth, with projections indicating an expansion from US$6.34 billion in 2023 to US$17.58 billion by 2032. This represents a robust compound annual growth rate (CAGR) of 11.99% from 2024 to 2032. The market's growth is primarily driven by an aging population, increasing prevalence of cardiovascular diseases, and advancements in minimally invasive procedures.
Transcatheter Heart…
Transcatheter Cardiac Pacemaker Market Size 2024 to 2031.
Market Overview and Report Coverage
A Transcatheter Cardiac Pacemaker is a cutting-edge medical device used in the treatment of heart rhythm disorders by delivering electrical impulses to regulate the heartbeat. The market for these innovative devices is expected to experience significant growth in the coming years.
The Transcatheter Cardiac Pacemaker Market is projected to grow at a CAGR of 12.60% during the forecasted period, driven by factors such as…
Transcatheter Heart Valve Replacement Repair Market
The Transcatheter Heart Valve Replacement Repair Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire…
Recent Study on Transcatheter Valve Market: 2019-2026 Global Industry Key Compan …
The Global Transcatheter Valve Market is high risk of complications from surgical aortic valve replacement is driving the growth of the market. However, high risk of blood vessel tearing yet remains major restraints to the market.
Get Sample copy @ https://www.orianresearch.com/request-sample/1099645
Key players profiled in the report includes: Boston Scientific Corporation, Direct Flow medical, Edwards Lifesciences Corporation, HLT, JenaValve Technology, Medtronic plc, Meril Life Sciences Pvt. Ltd., St. Jude Medical, SYMETIS…
